TQC2731 injection

TQC2731 · Chia Tai Tianqing Pharmaceutical Group; Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TQC2731 injection, covering 2025-11-20 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps [Phase 3]